CAMC has received the American Heart Association/American Stroke Association's Get With The Guidelines®–Stroke Silver Quality Achievement Award. The award recognizes CAMC's commitment and success in implementing a higher standard of stroke care by ensuring that stroke patients receive treatment according to nationally accepted standards and recommendations.
To receive the Get With The Guidelines-Stroke Silver Quality Achievement Award, CAMC consistently complied, for at least one year, with the requirements in the Get With The Guidelines–Stroke program. These include aggressive use of medications like antithrombotics, anticoagulation therapy, deep vein thrombosis prophylaxis, cholesterol reducing drugs and smoking cessation. This 12-month evaluation period is the second in an ongoing self-evaluation by the hospital to continually reach the 85 percent compliance level needed to sustain this award.
In addition to the Get With The Guideline-Stroke award, CAMC has also been recognized as a recipient of the association's Target: Stroke Honor Roll, for improving stroke care. Over the past quarter, at least 50 percent of the hospital's eligible ischemic stroke patients have received tissue plasminogen activator, or tPA, within 60 minutes of arriving at the hospital (known as 'door-to-needle' time). A thrombolytic, or clot-busting agent, tPA is the only drug approved by the U.S. Food and Drug Administration for the urgent treatment of ischemic stroke. If given intravenously in the first three hours after the start of stroke symptoms, tPA has been shown to significantly reverse the effects of stroke and reduce permanent disability.
Get With The Guidelines® is the American Heart Association/American Stroke Association's hospital-based quality improvement program that empowers health care teams to save lives and reduce health care costs by helping hospitals follow evidence-based guidelines and recommendations. For more information, visit heart.org/quality.